Cytokinetics, Incorporated · NASDAQ:CYTK
Daly James M received 195 Cytokinetics, Incorporated shares as an award (Form 4)
Traded Oct 16, 2026 · Filed Oct 20, 2026
On Oct 16, 2026, Daly James M (Director) received 195 Cytokinetics, Incorporated shares as an award at US$63.92 for US$12,464, leaving 3,585 shares. Filed Oct 20, 2026 (Form 4).
- Awarded
- 195 shares
- Price
- US$63.92
- Value
- US$12,464
- Holding after
- 3,585 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Stock | Award | 195 | US$63.92 | 3,585 | Direct |
Source
Download original · View original at SEC
Related
- Cytokinetics, Incorporated
- Daly James M
- Cytokinetics, Incorporated shareholders
- Form 4 · Daly James M · Jul 16, 2026
- Form 4 · Daly James M · May 27, 2026
- Form 4 · Daly James M · Apr 15, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026
- Form 4 · Kaye Edward M. MD · Oct 20, 2026